Identification of mitochondria-related biomarkers in liver fibrosis via interpretable machine learning and WGCNA: transcriptomic analysis and In Vivo validation - Summary - MDSpire

Identification of mitochondria-related biomarkers in liver fibrosis via interpretable machine learning and WGCNA: transcriptomic analysis and In Vivo validation

  • By

  • Yupeng Ma

  • Xinhong Chen

  • Lujin Yin

  • Yongbin Chi

  • Denghai Zhang

  • Xiaocheng Xue

  • Xue Zhang

  • May 28, 2026

  • 0 min

Share

Objective:

To identify key mitochondria-related genes associated with liver fibrosis and explore their mechanistic roles and therapeutic potential using a multi-omics mining strategy.

Key Findings:
  • 38 mitochondria-related DEGs were identified in CCl4-induced fibrosis, indicating potential biomarkers for liver fibrosis.
  • Machine learning prioritized Acot9, Aldh1b1, and Pck2 as key targets, suggesting their roles in fibrogenesis.
  • ACOT9, ALDH1B1, and PCK2 were upregulated in fibrotic liver tissue, correlating with disease severity.
  • Silencing ACOT9 in human LX-2 cells downregulated classical fibrotic markers, highlighting its regulatory role.
Interpretation:

ACOT9 was identified as a key mitochondrial target associated with liver fibrosis, with its upregulation linked to fibrogenesis through mechanisms that warrant further investigation.

Limitations:
Conclusion:

ACOT9's modulation of fibrosis markers in hepatic stellate cells highlights its mechanistic relevance and potential as a therapeutic target.

Original Source(s)

Related Content